Nab-paclitaxel plus cisplatin versus gemcitabine plus cisplatin as first-line treatment in advanced biliary tract cancer: results of a multicentre, randomised, phase II trial

Authors

Qiao Huang (ORCID: https://orcid.org/0000-0002-9044-2464)
Ping Qiu (ORCID: https://orcid.org/0000-0003-4090-5704)
Shunfang Liu (ORCID: https://orcid.org/0000-0002-6267-6482)
Yuhong Dai
Hui Peng (ORCID: https://orcid.org/0000-0002-8901-1384)
Mingsheng Zhang (ORCID: https://orcid.org/0000-0002-8929-9349)
Liang Zhuang (ORCID: https://orcid.org/0009-0000-6087-3709)
Yang Xiao (ORCID: https://orcid.org/0000-0002-7739-4146)
Hong Qiu (ORCID: https://orcid.org/0000-0001-9303-3335)
Li Sun
Haisheng Xu (ORCID: https://orcid.org/0000-0001-9728-9864)
Qiang Fu (ORCID: https://orcid.org/0000-0002-6863-0098)
Yanmei Zou
Henghui Cheng

Institutions

Xiangyang Central Hospital (CN)
Jingzhou Central Hospital (CN)
Yichang Central People's Hospital (CN)
Tongji Hospital (CN)
Huazhong University of Science and Technology (CN)

Publication Details

Journal: BMC Cancer
Published: 2025-08-16
DOI: https://doi.org/10.1186/s12885-025-14581-3
Primary Topic: Cholangiocarcinoma and Gallbladder Cancer Studies
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Beijing Xisike Clinical Oncology Research Foundation
Tongji University

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Nab-paclitaxel plus cisplatin versus gemcitabine plus cisplatin as first-line treatment in advanced biliary tract cancer: results of a multicentre, randomised, phase II trial

Qiao Huang, Ping Qiu, Shunfang Liu, Yuhong Dai et al.

Aug 16, 2025

BMC Cancer

Cholangiocarcinoma and Gallbladder Cancer Studies

article

Nab-paclitaxel plus cisplatin versus gemcitabine plus cisplatin as first-line treatment in advanced biliary tract cancer: results of a multicentre, randomised, phase II trial

Qiao Huang, Ping Qiu, Shunfang Liu, Yuhong Dai, Hui Peng, Mingsheng Zhang, Liang Zhuang, Yang Xiao, Hong Qiu, Li Sun, Haisheng Xu, Qiang Fu, Yanmei Zou, Henghui Cheng

August 16, 2025article en

Abstract

No abstract available for this paper.

BMC CancerVol. 25(1)

Xiangyang Central Hospital (CN), Jingzhou Central Hospital (CN), Yichang Central People's Hospital (CN), Tongji Hospital (CN), Huazhong University of Science and Technology (CN)

Beijing Xisike Clinical Oncology Research Foundation, Tongji University

Good health and well-being

Openalex Percentile: Top 66%

Cholangiocarcinoma and Gallbladder Cancer Studies

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.